Anti-lewis y antibody and pro-antibody thereof

TW202639604APending Publication Date: 2026-10-01GLYCONEX
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
TW114143162
Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
Priority Date
2024-11-07
Filing Date
2025-11-06
Publication Date
2026-10-01

Smart Images

  • Figure TWG2TA001078435_001
    Figure TWG2TA001078435_001
  • Figure TWG2TA001078435_002
    Figure TWG2TA001078435_002
  • Figure TWG2TA001078435_003
    Figure TWG2TA001078435_003
Patent Text Reader

Abstract

The present disclosure relates to cancer therapies, in particular immunotherapies using antibodies or pro-antibodies to target Lewis Y antigens on tumor cells, thereby eliciting antibody-dependent cellular cytotoxicity (ADCC), complement-mediated cytotoxicity (CDC), and antibody-dependent cellular phagocytosis (ADCP).
Need to check novelty before this filing date? Find Prior Art